There is evidence that polymorphisms from the FTO alpha-ketoglutarate dependent dioxygenase (renamed from fat mass and obesity-associated FTO): rs9939609, rs8050135, and rs1420185 are associated with higher risk for MetS [31–33]. This evidence concerns the gene FTO and metabolic syndrome.